UnknownNot Applicable

Progesterone Primed Ovarian Stimulation Protocol Versus Antagonist Protocol for PCO Patient

210 participantsStarted 2023-06-01

Plain-language summary

this study is designed to compare the Progesterone primed ovarian stimulation protocol versus the antagonist protocol as a method to stimulate PCO patients in ICSI cycles to decrease cost and decrease OHSS.

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- 1. PCO patients based on Rotterdam criteria (2003), including polycystic ovaries, oligo-anovulation, as well as the biochemical or clinical signs of hyperandrogenism (Rotterdam et al, 2003). 2\. Age less than 40 years old. 3. Primary infertility for 2 years and secondary infertility for 1 year. Exclusion Criteria: \- Non-PCO patients as: * Congenital adrenal hyperplasia * Hyperprolactinemia. * Recurrent implantation failure. * Hydrosalpinx. * Uterine pathology. * Uncontrolled medical disorder eg DM, HTN * Male factor infertility.

What they're measuring

The number of oocytes retrieved per patient

Timeframe: 12 months

The number of MII oocytes/per patient

Timeframe: 12 months

The fertilization rate/per patient.

Timeframe: 12 months

Number of frozen embryos/per patient

Timeframe: 12 month

Trial details

NCT IDNCT05847660

SponsorFayoum University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-01

Contact for this trial

rehab A aboshama, Ass Professor

01156608221 ras07@fayoum.edu.eg

View on ClinicalTrials.gov More Polycystic Ovary Syndrome trials